Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
cytarabin 100 mg/ml, injektionsvätska, lösning, flaska 5 ml |
Is a |
False |
Cytarabine-containing product in parenteral dose form |
Inferred relationship |
Some |
|
cytarabin 100 mg/ml, injektionsvätska, lösning, flaska 20 ml |
Is a |
False |
Cytarabine-containing product in parenteral dose form |
Inferred relationship |
Some |
|
cytarabin 20 mg/ml, injektionsvätska, lösning, flaska 25 ml |
Is a |
False |
Cytarabine-containing product in parenteral dose form |
Inferred relationship |
Some |
|
cytarabin 1 g, pulver till injektionsvätska, flaska |
Is a |
False |
Cytarabine-containing product in parenteral dose form |
Inferred relationship |
Some |
|
cytarabin 20 mg/ml, injektionsvätska, lösning 5 ml |
Is a |
False |
Cytarabine-containing product in parenteral dose form |
Inferred relationship |
Some |
|
cytarabin 100 mg/ml, injektionsvätska, lösning, flaska 1 ml |
Is a |
False |
Cytarabine-containing product in parenteral dose form |
Inferred relationship |
Some |
|
cytarabin 100 mg/ml, injektionsvätska, lösning, flaska 10 ml |
Is a |
False |
Cytarabine-containing product in parenteral dose form |
Inferred relationship |
Some |
|
cytarabin 100 mg, pulver till injektionsvätska, flaska |
Is a |
False |
Cytarabine-containing product in parenteral dose form |
Inferred relationship |
Some |
|
Product containing precisely cytarabine 500 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Is a |
False |
Cytarabine-containing product in parenteral dose form |
Inferred relationship |
Some |
|
liposomalt cytarabin 50 mg/5 ml, injektionsvätska, flaska 5 ml |
Is a |
False |
Cytarabine-containing product in parenteral dose form |
Inferred relationship |
Some |
|
cytarabin 500 mg/flaska, pulver till injektionsvätska |
Is a |
False |
Cytarabine-containing product in parenteral dose form |
Inferred relationship |
Some |
|
cytarabin 1 g/flaska, pulver till injektionsvätska |
Is a |
False |
Cytarabine-containing product in parenteral dose form |
Inferred relationship |
Some |
|
cytarabin 2 g/flaska, pulver till injektionsvätska |
Is a |
False |
Cytarabine-containing product in parenteral dose form |
Inferred relationship |
Some |
|
Product containing precisely cytarabine 50 milligram/1 milliliter conventional release suspension for injection (clinical drug) |
Is a |
False |
Cytarabine-containing product in parenteral dose form |
Inferred relationship |
Some |
|
cytarabin 1 g/10 ml, injektionsvätska, lösning, flaska |
Is a |
False |
Cytarabine-containing product in parenteral dose form |
Inferred relationship |
Some |
|
cytarabin 100 mg/ml, injektionsvätska, lösning, flaska |
Is a |
False |
Cytarabine-containing product in parenteral dose form |
Inferred relationship |
Some |
|
cytarabin 2 g/20 ml, injektionsvätska, lösning, flaska |
Is a |
False |
Cytarabine-containing product in parenteral dose form |
Inferred relationship |
Some |
|
cytarabin 500 mg/5 ml, injektionsvätska, lösning, flaska |
Is a |
False |
Cytarabine-containing product in parenteral dose form |
Inferred relationship |
Some |
|
cytarabin 500 mg/25 ml, injektionsvätska, lösning, flaska |
Is a |
False |
Cytarabine-containing product in parenteral dose form |
Inferred relationship |
Some |
|
Product containing only cytarabine in parenteral dose form (medicinal product form) |
Is a |
True |
Cytarabine-containing product in parenteral dose form |
Inferred relationship |
Some |
|